Gunderson Dettmer Advised Sales Agents on Arcus Biosciences, Inc. “At-the-Market” Offering
February 28, 2023 – Client News
Gunderson Dettmer advised sales agents Goldman Sachs & Co. LLC and SVB Securities in a proposed $200 million “at-the-market” offering of common stock for Arcus Biosciences, Inc. Public companies partner Jeffrey Vetter and corporate partner Marcia Hatch and associates Elena Vespoli, Daniel Reichert, Sherrie Quinn, Leanne Gould, and Phoebe Hung led the team advising the sales agents.
Arcus, which trades on the New York Stock Exchange under the ticker symbol “RCUS,” is a clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer.
Goldman Sachs & Co. LLC
Arcus Biosciences, Inc.